Abstract
This Practice Point commentary discusses a recent paper in which Vikse et al. demonstrated that history of preeclampsia is a marker for an increased risk of end-stage renal disease (ESRD). Among women with preeclampsia, giving birth to a low-birth-weight or preterm infant further increased the relative risk of ESRD, which suggests that more-severe preeclampsia might be a marker for an even higher risk of ESRD. Although the precise mechanisms for the association between preeclampsia and ESRD were not demonstrated, the common risk factors of preeclampsia and chronic kidney disease might explain these observations; alternatively, preeclampsia itself might induce renal injury by suppressing the activity of renoprotective angiogenic factors. This commentary emphasizes that although the absolute risk of developing ESRD is low, women with a history of preeclampsia should undergo renal follow-up (including estimation of glomerular filtration rate, measurement of blood pressure and quantification of proteinuria), a practice which might also decrease risk of cardiovascular disease.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Angiotensin II type 1 receptor agonistic autoantibody blockade improves postpartum hypertension and cardiac mitochondrial function in rat model of preeclampsia
Biology of Sex Differences Open Access 02 November 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Vikse BE et al. (2008) Preeclampsia and the risk of end-stage renal disease. N Engl J Med 359: 800–809
Hertig A et al. (2008) How should women with pre-eclampsia be followed up? New insights from mechanistic studies. Nat Clin Pract Nephrol 4: 503–509
Vikse BE et al. (2006) Adverse perinatal outcome and later kidney biopsy in the mother. J Am Soc Nephrol 17: 837–845
Maynard SE et al. (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111: 649–658
Sugimoto H et al. (2003) Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem 278: 12605–12608
Eremina V et al. (2003) Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 111: 707–716
Eremina V et al. (2008) VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 358: 1129–1136
Hamad RR et al. (2007) Decreased flow-mediated dilatation is present 1 year after pre-eclamptic pregnancy. J Hypertens 25: 2301–2307
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Hamano, T. Women with a history of preeclampsia should be monitored for the onset and progression of chronic kidney disease. Nat Rev Nephrol 5, 8–9 (2009). https://doi.org/10.1038/ncpneph0991
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpneph0991